Transplantation

Article	Citations
KDIGO Clinical Practice Guideline on the Evaluation and Management of Candidates for Kidney Transplantation	237
COVID-19 and Solid Organ Transplantation: A Review Article	210
Recommended Treatment for Antibody-mediated Rejection After Kidney Transplantation: The 2019 Expert Consensus From the Transplantion Society Working Group	144
Risk of Breakthrough SARS-CoV-2 Infections in Adult Transplant Recipients	122
The RECOVAC Immune-response Study: The Immunogenicity, Tolerability, and Safety of COVID-19 Vaccination in Patients With Chronic Kidney Disease, on Dialysis, or Living With a Kidney Transplant	101
Poor Anti-SARS-CoV-2 Humoral and T-cell Responses After 2 Injections of mRNA Vaccine in Kidney Transplant Recipients Treated With Belatacept	98
Antibody Response to a Fourth Dose of a SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case Series	91
Early Experience With COVID-19 and Solid Organ Transplantation at a US High-volume Transplant Center	85
Outcomes of Coronavirus Infectious Disease -19 (COVID-19) in Solid Organ Transplant Recipients	80
Global Transplantation COVID Report March 2020	77
HLA and AB0 Polymorphisms May Influence SARS-CoV-2 Infection and COVID-19 Severity	70
Clinical Profile and Outcome of COVID-19 in 250 Kidney Transplant Recipients: A Multicenter Cohort Study From India	68
COVID-19 in Lung Transplant Recipients	65
Liver Transplantation for Hepatocellular Carcinoma. Working Group Report from the ILTS Transplant Oncology Consensus Conference	64
Clinical Implementation of Prolonged Liver Preservation and Monitoring Through Normothermic Machine Perfusion in Liver Transplantation	64
Life-supporting Kidney Xenotransplantation From Genetically Engineered Pigs in Baboons: A Comparison of Two Immunosuppressive Regimens	63
Incidence and Risks for Nonalcoholic Fatty Liver Disease and Steatohepatitis Post-liver Transplant: Systematic Review and Meta-analysis	63
Real-world Effectiveness of the Pfizer-BioNTech BNT162b2 and Oxford-AstraZeneca ChAdOx1-S Vaccines Against SARS-CoV-2 in Solid Organ and Islet Transplant Recipients	62
Cellular and Humoral Immune Responses After 3 Doses of BNT162b2 mRNA SARS-CoV-2 Vaccine in Kidney Transplant	61
Safety of Everolimus With Reduced Calcineurin Inhibitor Exposure in De Novo Kidney Transplants: An Analysis From the Randomized TRANSFORM Study	61
New Insights Into the Indications for Intestinal Transplantation: Consensus in the Year 2019	61
Safety and Reactogenicity of 2 Doses of SARS-CoV-2 Vaccination in Solid Organ Transplant Recipients	60
Kidney Transplant Recipients Rarely Show an Early Antibody Response Following the First COVID-19 Vaccine Administration	58
Two Doses of SARS-CoV-2 Vaccines Reduce Risk of Death Due to COVID-19 in Solid Organ Transplant Recipients: Preliminary Outcomes From a UK Registry Linkage Analysis	58
High-risk Corneal Transplantation: Recent Developments and Future Possibilities	56

Early Impact of COVID-19 on Solid Organ Transplantation in the United States	56
COVID-19 Outcomes Among Solid Organ Transplant Recipients: A Case-control Study	54
Summary of the Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice Guideline on the Evaluation and Management of Candidates for Kidney Transplantation	54
Safety of the First Dose of SARS-CoV-2 Vaccination in Solid Organ Transplant Recipients	53
Respiratory and Gastrointestinal COVID-19 Phenotypes in Kidney Transplant Recipients	50
Favorable Outcomes of Liver Transplantation from Controlled Circulatory Death Donors Using Normothermic Regional Perfusion Compared to Brain Death Donors	50
Normothermic Ex Vivo Kidney Perfusion Improves Early DCD Graft Function Compared With Hypothermic Machine Perfusion and Static Cold Storage	50
How to Preserve Liver Grafts From Circulatory Death With Long Warm Ischemia? A Retrospective Italian Cohort Study With Normothermic Regional Perfusion and Hypothermic Oxygenated Perfusion	50
Immunogenicity and Reactogenicity After SARS-CoV-2 mRNA Vaccination in Kidney Transplant Recipients Taking Belatacept	50
CD38 Antibody Daratumumab for the Treatment of Chronic Active Antibody-mediated Kidney Allograft Rejection	48
Development of COVID-19 Infection in Transplant Recipients After SARS-CoV-2 Vaccination	47
Antibody Response to the Janssen COVID-19 Vaccine in Solid Organ Transplant Recipients	47
Review of Current Machine Perfusion Therapeutics for Organ Preservation	47
Impact of Tocilizumab (Anti–IL-6R) Treatment on Immunoglobulins and Anti-HLA Antibodies in Kidney Transplant Patients With Chronic Antibody-mediated Rejection	46
Histopathologic Findings in the Explant Lungs of a Patient With COVID-19 Treated With Bilateral Orthotopic Lung Transplant	45
Serological Response to the BNT162b2 COVID-19 mRNA Vaccine in Adolescent and Young Adult Kidney Transplant Recipients	45
COVID-19 in Solid Organ Transplantation: A Matched Retrospective Cohort Study and Evaluation of Immunosuppression Management	44
Organ Donation and Transplantation During the COVID-19 Pandemic: A Summary of the Spanish Experience	44
Does Racial Disparity in Kidney Transplant Waitlisting Persist After Accounting for Social Determinants of Health?	44
Effects of Oxygen During Long-term Hypothermic Machine Perfusion in a Porcine Model of Kidney Donation After Circulatory Death	44
Phase I/II Trial of Liver–derived Mesenchymal Stem Cells in Pediatric Liver–based Metabolic Disorders: A Prospective, Open Label, Multicenter, Partially Randomized, Safety Study of One Cycle of Hetero	44
Use of Eculizumab for Active Antibody-mediated Rejection That Occurs Early Post–kidney Transplantation: A Consecutive Series of 15 Cases	43
Design, Analysis, and Pitfalls of Clinical Trials Using Ex Situ Liver Machine Perfusion: The International Liver Transplantation Society Consensus Guidelines	43
The Causes of Kidney Allograft Failure: More Than Alloimmunity. A Viewpoint Article	43
Evidence of SARS-CoV-2 Infection in Cells, Tissues, and Organs and the Risk of Transmission Through Transplantation	43
Perceptions and Practices Regarding Frailty in Kidney Transplantation: Results of a National Survey	42
A Fourth Dose of COVID-19 Vaccine Does Not Induce Neutralization of the Omicron Variant Among Solid Organ Transplant Recipients With Suboptimal Vaccine Response	42
Liver Transplantation for Cholangiocarcinoma and Mixed Hepatocellular Cholangiocarcinoma: Working Group Report From the ILTS Transplant Oncology Consensus Conference	42
Casirivimab-imdevimab for Treatment of COVID-19 in Solid Organ Transplant Recipients: An Early Experience	42
Long-term Outcomes Following Kidney Transplantation From Donors With Acute Kidney Injury	40
Guidelines for Perioperative Care for Liver Transplantation: Enhanced Recovery After Surgery (ERAS) Recommendations	40
Renal Protection Against Ischemia Reperfusion Injury: Hemoglobin-based Oxygen Carrier-201 Versus Blood as an Oxygen Carrier in Ex Vivo Subnormothermic Machine Perfusion	40
Humoral Response of Renal Transplant Recipients to the BNT162b2 SARS-CoV-2 mRNA Vaccine Using Both RBD IgG and Neutralizing Antibodies	39
Mortality Rates in Transplant Recipients and Transplantation Candidates in a High-prevalence COVID-19 Environment	37
Exercise for Solid Organ Transplant Candidates and Recipients: A Joint Position Statement of the Canadian Society of Transplantation and CAN-RESTORE	37
Initial Report From a Swedish High-volume Transplant Center After the First Wave of the COVID-19 Pandemic	37
Development and Validation of a Multiplex, Bead-based Assay to Detect Antibodies Directed Against SARS-CoV-2 Proteins	37
Optimizing Mycophenolic Acid Exposure in Kidney Transplant Recipients: Time for Target Concentration Intervention	36
Long-term Graft Survival and Graft Function Following Pregnancy in Kidney Transplant Recipients: A Systematic Review and Meta-analysis	36
Imlifidase Desensitization in Crossmatch-positive, Highly Sensitized Kidney Transplant Recipients: Results of an International Phase 2 Trial (Highdes)	36
The TOMATO Study (Tacrolimus Metabolization in Kidney Transplantation): Impact of the Concentration–Dose Ratio on Death-censored Graft Survival	35
Is it Safe to Be Transplanted From Living Donors Who Recovered From COVID-19? Experience of 31 Kidney Transplants in a Multicenter Cohort Study From India	35
Safety and Risk Factors of Pure Laparoscopic Living Donor Right Hepatectomy: Comparison to Open Technique in Propensity Score–matched Analysis	34
Ethical Issues in the COVID Era: Doing the Right Thing Depends on Location, Resources, and Disease Burden	34
Analytical Validation of a Single-nucleotide Polymorphism-based Donor-derived Cell-free DNA Assay for Detecting Rejection in Kidney Transplant Patients	34
Dallas UtErus Transplant Study: Early Outcomes and Complications of Robot-assisted Hysterectomy for Living Uterus Donors	33
Assessing the Complex Causes of Kidney Allograft Loss	33
Surveillance for HCC After Liver Transplantation: Increased Monitoring May Yield Aggressive Treatment Options and Improved Postrecurrence Survival	33
Sarcopenia Predicts Post-transplant Mortality in Acutely Ill Men Undergoing Urgent Evaluation and Liver Transplantation	33
Cannabis Dependence or Abuse in Kidney Transplantation: Implications for Posttransplant Outcomes	32

An Outpatient Hospital-based Exercise Training Program for Patients With Cirrhotic Liver Disease Awaiting Transplantation: A Feasibility Trial	32
Assessing the Limits in Kidney Transplantation: Use of Extremely Elderly Donors and Outcomes in Elderly Recipients	32
Experience With LDLT in Patients With Hepatocellular Carcinoma and Portal Vein Tumor Thrombosis Postdownstaging	32
Donor Warm Ischemia Time in DCD Liver Transplantation—Working Group Report From the ILTS DCD, Liver Preservation, and Machine Perfusion Consensus Conference	32
Outcomes of Renal Transplant Recipients With SARS-CoV-2 Infection in the Eye of the Storm: A Comparative Study With Waitlisted Patients	32
Experience With Early Sorafenib Treatment With mTOR Inhibitors in Hepatocellular Carcinoma Recurring After Liver Transplantation	32
Interleukin-6: An Important Mediator of Allograft Injury	32
The Global Impact of COVID-19 on Solid Organ Transplantation: Two Years Into a Pandemic	31
Posttransplant Management of Recipients Undergoing Liver Transplantation for Hepatocellular Carcinoma. Working Group Report From the ILTS Transplant Oncology Consensus Conference	31
Tacrolimus Intrapatient Variability, Time in Therapeutic Range, and Risk of De Novo Donor–Specific Antibodies	31
Early Changes in Kidney Transplant Immunosuppression Regimens During the COVID-19 Pandemic	31
Donor-derived Cell-free DNA in Solid-organ Transplant Diagnostics: Indications, Limitations, and Future Directions	31
Letermovir as Salvage Therapy for Cytomegalovirus Infection in Transplant Recipients	31
The Monitoring of Donor-derived Cell-free DNA in Kidney Transplantation	31
Breakthrough COVID-19 Infections After mRNA Vaccination in Solid Organ Transplant Recipients in Miami, Florida	30
Kidney Transplant From Uncontrolled Donation After Circulatory Death: Contribution of Normothermic Regional Perfusion	30
Perfusate Analysis During Dual Hypothermic Oxygenated Machine Perfusion of Liver Grafts: Correlations With Donor Factors and Early Outcomes	30
Impact of a Mobile Health Intervention on Long-term Nonadherence After Lung Transplantation: Follow-up After a Randomized Controlled Trial	30
Novel Organ Perfusion and Preservation Strategies in Transplantation – Where Are We Going in the United Kingdom?	29
COVID-19 Clinical Outcomes in Solid Organ Transplant Recipients During the Omicron Surge	28
Update on C1 Esterase Inhibitor in Human Solid Organ Transplantation	28
The Impact of Preexisting and Post-transplant Diabetes Mellitus on Outcomes Following Liver Transplantation	28
When Is a Critically Ill Cirrhotic Patient Too Sick to Transplant? Development of Consensus Criteria by a Multidisciplinary Panel of 35 International Experts	28
Frailty as a Predictor of Mortality in Patients With Interstitial Lung Disease Referred for Lung Transplantation	28
Liver Transplantation Using Uncontrolled Donors After Circulatory Death: A 10-year Single-center Experience	27
Biomarkers of Cytokine Release Syndrome Predict Disease Severity and Mortality From COVID-19 in Kidney Transplant Recipients	27
Racial and Ethnic Disparities in Kidney Transplant Access Within a Theoretical Context of Medical Eligibility	27
Comparing Glycaemic Benefits of Active Versus Passive Lifestyle Intervention in Kidney Allograft Recipients: A Randomized Controlled Trial	27
The Magnitude and Functionality of SARS-CoV-2 Reactive Cellular and Humoral Immunity in Transplant Population Is Similar to the General Population Despite Immunosuppression	27
Poor Outcomes With the Use of Checkpoint Inhibitors in Kidney Transplant Recipients	26
Solid Organ Transplantation in the Era of COVID-19: Lessons from France	26
DSA Are Associated With More Graft Injury, More Fibrosis, and Upregulation of Rejection-associated Transcripts in Subclinical Rejection	26
Antibodies Against ARHGDIB and ARHGDIB Gene Expression Associate With Kidney Allograft Outcome	26
The Full Spectrum of COVID-19 Development and Recovery Among Kidney Transplant Recipients	26
The Efficacy and Safety of SGLT2 Inhibitor in Diabetic Kidney Transplant Recipients	25
Antibody Kinetics and Durability in SARS-CoV-2 mRNA Vaccinated Solid Organ Transplant Recipients	25
Differential Regulation of T-cell Immunity and Tolerance by Stromal Laminin Expressed in the Lymph Node	25
Liver Transplantation in Acute-on-chronic Liver Failure	25
Bilirubin Improves the Quality and Function of Hypothermic Preserved Islets by Its Antioxidative and Anti-inflammatory Effect	24
Association Between Neighborhood-level Socioeconomic Deprivation and the Medication Level Variability Index for Children Following Liver Transplantation	24
Recommendations for Donor and Recipient Selection and Risk Prediction: Working Group Report From the ILTS Consensus Conference in DCD Liver Transplantation	24
Single-cell Transcriptomics and Solid Organ Transplantation	24
Immunosuppression and Reproductive Health After Kidney Transplantation	24
Impaired Humoral Response to Third Dose of BNT162b2 mRNA COVID-19 Vaccine Despite Detectable Spike Protein–specific T cells in Lung Transplant Recipients	24
Prediction of Perioperative Mortality of Cadaveric Liver Transplant Recipients During Their Evaluations	24
Anti-SARS-CoV-2 Monoclonal Antibodies in Solid-organ Transplant Patients	24
Regulations and Procurement Surgery in DCD Liver Transplantation: Expert Consensus Guidance From the International Liver Transplantation Society	23
What Therapeutic Regimen Will Be Optimal for Initial Clinical Trials of Pig Organ Transplantation?	23
Recipient Comorbidity and Survival Outcomes After Kidney Transplantation: A UK-wide Prospective Cohort Study	23
Correlation of Donor-derived Cell-free DNA With Histology and Molecular Diagnoses of Kidney Transplant Biopsies	23
Cystatin C and Sarcopenia Predict Acute on Chronic Liver Failure Development and Mortality in Patients on the Liver Transplant Waiting List	23
Liver Transplantation for Colorectal and Neuroendocrine Liver Metastases and Hepatoblastoma. Working Group Report From the ILTS Transplant Oncology Consensus Conference	23
Oral and Inhaled Ribavirin Treatment for Respiratory Syncytial Virus Infection in Lung Transplant Recipients	23
Inducing Transient Mixed Chimerism for Allograft Survival Without Maintenance Immunosuppression With Combined Kidney and Bone Marrow Transplantation: Protocol Optimization	23
Improved Organ Utilization and Better Transplant Outcomes With In Situ Normothermic Regional Perfusion in Controlled Donation After Circulatory Death	22
Mucosa and Rejection in Facial Vascularized Composite Allotransplantation: A Systematic Review	22
A Nationwide Survey of Hepatitis E Virus Infection and Chronic Hepatitis in Heart and Kidney Transplant Recipients in Japan	22
Limited Availability of Deceased Uterus Donors: A Transatlantic Perspective	22
Immune Response Post–SARS-CoV-2 mRNA Vaccination in Kidney Transplant Recipients Receiving Belatacept	22
Nanotechnology Applications in Transplantation Medicine	22
Sex and Gender Considerations in Transplant Research: A Scoping Review	22
Imlifidase Inhibits HLA Antibody-mediated NK Cell Activation and Antibody-dependent Cell-mediated Cytotoxicity (ADCC) In Vitro	22
Protocol Biopsies in Patients With Subclinical De Novo Donor-specific Antibodies After Kidney Transplantation: A Multicentric Study	22
Late Graft Loss After Kidney Transplantation: Is “Death With Function” Really Death With a Functioning Allograft?	22
Uncontrolled Donation After Circulatory Death: A Unique Opportunity	21
Clinical Outcomes After Liver Transplantation in Patients With Portopulmonary Hypertension	21
The Future Role of Machine Learning in Clinical Transplantation	21
COVID-19 in Kidney Transplant Recipients Vaccinated With Oxford–AstraZeneca COVID-19 Vaccine (Covishield): A Single-center Experience From India	21
Growth Patterns After Kidney Transplantation in European Children Over the Past 25 Years: An ESPN/ERA-EDTA Registry Study	21
Perfusate Enzymes and Platelets Indicate Early Allograft Dysfunction After Transplantation of Normothermically Preserved Livers	21
Letermovir for Difficult to Treat Cytomegalovirus Infection in Lung Transplant Recipients	21
Mesenchymal Stromal Cells in Solid Organ Transplantation	21
Diagnostic Accuracy of Donor-derived Cell-free DNA in Renal-allograft Rejection: A Meta-analysis	21
A Programmatic Response, Including Bamlanivimab or Casirivimab-imdevimab Administration, Reduces Hospitalization and Death in COVID-19 Positive Abdominal Transplant Recipients	21
Everolimus Initiation With Early Calcineurin Inhibitor Withdrawal in De Novo Heart Transplant Recipients: Long-term Follow-up From the Randomized SCHEDULE Study	21
Membranous Nephropathy Posttransplantation: An Update of the Pathophysiology and Management	21
Donor-specific B Cell Memory in Alloimmunized Kidney Transplant Recipients: First Clinical Application of a Novel Method	21
Efficacy and Safety of Everolimus With Reduced Tacrolimus in Liver Transplant Recipients: 24-month Results From the Pooled Analysis of 2 Randomized Controlled Trials	20
Liver Transplantation of HCV-viremic Donors Into HCV-negative Recipients in the United States: Increasing Frequency With Profound Geographic Variation	20
Multilevel Correlates of Immunosuppressive Nonadherence in Kidney Transplant Patients: The Multicenter ADHERE BRAZIL Study	20

Renal Normothermic Machine Perfusion: The Road Toward Clinical Implementation of a Promising Pretransplant Organ Assessment Tool	20
Influence of Different Partial Pressures of Oxygen During Continuous Hypothermic Machine Perfusion in a Pig Kidney Ischemia-reperfusion Autotransplant Model	20
COVID-19 in Solid Organ Transplant Recipients in Spain Throughout 2020: Catching the Wave?	20
First Report on Ex Vivo Delivery of Paracrine Active Human Mesenchymal Stromal Cells to Liver Grafts During Machine Perfusion	20
A Report of 85 Cases of COVID-19 and Abdominal Transplantation From a Single Center: What Are the Associated Factors With Death Among Organ Transplantation Patients	20
COVID-19 Therapeutics for Solid Organ Transplant Recipients; 6 Months Into the Pandemic: Where Are We Now?	20
Advances in Kidney Preservation Techniques and Their Application in Clinical Practice	20
A Clinical Trial With Adoptive Transfer of Ex Vivo-induced, Donor-specific Immune-regulatory Cells in Kidney Transplantation—A Second Report	20
Impact of COVID-19 on Lung Allograft and Clinical Outcomes in Lung Transplant Recipients: A Case-control Study	20
Gender Disparities in Patients With Alcoholic Liver Disease Evaluated for Liver Transplantation	20
Liver Transplantation for Intrahepatic Cholangiocarcinoma: A Meta-analysis and Meta-regression of Survival Rates	20
Summary of International Recommendations for Donation and Transplantation Programs During the Coronavirus Disease Pandemic	20
Impact of Donor Hepatitis C Virus on Kidney Transplant Outcomes for Hepatitis C-positive Recipients in the Direct-acting Antiviral Era: Time to Revise the Kidney Donor Risk Index?	20
From Nonadherence to Adherence	19
Pathways to Clinical Cardiac Xenotransplantation	19
A Multicenter Cohort Study From India of 75 Kidney Transplants in Recipients Recovered After COVID-19	19
eHealth Interventions for Solid Organ Transplant Recipients: A Systematic Review and Meta-analysis of Randomized Controlled Trials	19
Nlrp3 Inflammasome Inhibitor MCC950 Ameliorates Obliterative Bronchiolitis by Inhibiting Th1/Th17 Response and Promoting Treg Response After Orthotopic Tracheal Transplantation in Mice	19
Primary Nonfunction of the Liver Allograft	19
Generation of GGTA1−/−β2M−/−CIITA−/− Pigs Using CRISPR/Cas9 Technology to Alleviate Xenogeneic Immune Reactions	19
Coronavirus Disease-19: Disease Severity and Outcomes of Solid Organ Transplant Recipients: Different Spectrums of Disease in Different Populations?	19
Efficacy of Convalescent Plasma to Treat Mild to Moderate COVID-19 in Kidney Transplant Patients: A Propensity Score Matching Analysis	19
Abdominal Normothermic Regional Perfusion in Donation After Circulatory Death: A Systematic Review and Critical Appraisal	19
De Novo Malignancy After Liver Transplantation: Risk Assessment, Prevention, and Management—Guidelines From the ILTS-SETH Consensus Conference	19
Classification of Distinct Patterns of Ischemic Cholangiopathy Following DCD Liver Transplantation: Distinct Clinical Courses and Long-term Outcomes From a Multicenter Cohort	19
Lung Transplantation for Severe Post–coronavirus Disease 2019 Respiratory Failure	19
Torque Teno Virus Load Is Associated With Subclinical Alloreactivity in Kidney Transplant Recipients: A Prospective Observational Trial	19
Practical Considerations for APOL1 Genotyping in the Living Kidney Donor Evaluation	19
HOUSES Index as an Innovative Socioeconomic Measure Predicts Graft Failure Among Kidney Transplant Recipients	19
Outcomes of Pediatric Liver Transplantation in Japan: A Report from the Registry of the Japanese Liver Transplantation Society	19
Donor Plasma Mitochondrial DNA Is Correlated with Posttransplant Renal Allograft Function	18
Normothermic Ex Vivo Kidney Perfusion for Human Kidney Transplantation: First North American Results	18
Thirty Years of Tacrolimus in Clinical Practice	18
Differential Influence of Donor Age Depending on the Indication for Liver Transplantation—A Collaborative Transplant Study Report	18
Metformin Attenuates Cyclosporine A-induced Renal Fibrosis in Rats	18
Enhanced Advocacy and Health Systems Training Through Patient Navigation Increases Access to Living-donor Kidney Transplantation	18
Evaluation of Recombinant Herpes Zoster Vaccine for Primary Immunization of Varicella-seronegative Transplant Recipients	18
Changing Trends in Liver Transplantation: Challenges and Solutions	18
Suggested Patient Selection Criteria for Initial Clinical Trials of Pig Kidney Xenotransplantation in the United States	18
Determinants of Immune Response to Anti–SARS-CoV-2 mRNA Vaccines in Kidney Transplant Recipients: A Prospective Cohort Study	18
Mammalian Target of Rapamycin Inhibitors Combined With Calcineurin Inhibitors as Initial Immunosuppression in Renal Transplantation: A Meta-analysis	18
Integrated Immunologic Monitoring in Solid Organ Transplantation: The Road Toward Torque Teno Virus-guided Immunosuppression	18
Glycocalyx Damage Within Human Liver Grafts Correlates With Graft Injury and Postoperative Graft Function After Orthotopic Liver Transplantation	18
Incidence and Outcomes of COVID-19 in Kidney and Liver Transplant Recipients With HIV: Report From the National HOPE in Action Consortium	18
Temporal Trends and Outcomes in Liver Transplantation for Recipients With HIV Infection in Europe and United States	18
Prospective Clinical, Virologic, and Immunologic Assessment of COVID-19 in Transplant Recipients	17
Renal Cell Carcinoma and Kidney Transplantation: A Narrative Review	17
Patients With Persistently Low MELD-Na Scores Continue to Be at Risk of Liver-related Death	17
Uterine Transplantation: Review of Livebirths and Reproductive Implications	17
The Outcomes of Portal Vein Reconstruction With Vein Graft Interposition in Pediatric Liver Transplantation for Small Children With Biliary Atresia	17
Neoadjuvant Chemoradiotherapy and Liver Transplantation for Unresectable Hilar Cholangiocarcinoma: The Irish Experience of the Mayo Protocol	17
A Review of Donor Acute Kidney Injury and Posttransplant Outcomes	17
Adding Insult on Injury: Immunogenic Role for Donor-derived Cell-free DNA?	17
Clinical Relevance of Posttransplant DSAs in Patients Receiving Desensitization for HLA-incompatible Kidney Transplantation	17
Bilateral Lung Transplantation Provides Better Long-term Survival and Pulmonary Function Than Single Lung Transplantation: A Systematic Review and Meta-analysis	17
Education Strategies in Dialysis Centers Associated With Increased Transplant Wait-listing Rates	17
Agmatine Attenuates Liver Ischemia Reperfusion Injury by Activating Wnt/β-catenin Signaling in Mice	17
Major Thromboembolic Complications in Liver Transplantation: The Role of Rotational Thromboelastometry and Cryoprecipitate Transfusion	17
Impact of Belatacept Conversion on Renal Function, Histology, and Gene Expression in Kidney Transplant Patients With Chronic Active Antibody-mediated Rejection	17
Donor Hepatectomy and Implantation Time Are Associated With Early Complications After Liver Transplantation: A Single-center Retrospective Study	17
Expanding Indications of Liver Transplantation in Spain: Consensus Statement and Recommendations by the Spanish Society of Liver Transplantation	17
Long-term Seroprotection of Varicella-zoster Immunization in Pediatric Liver Transplant Recipients	17
Live Birth Following Uterine Transplantation From a Nulliparous Deceased Donor	17
Trinational Study Exploring the Early Impact of the COVID-19 Pandemic on Organ Donation and Liver Transplantation at National and Unit Levels	17
Liver and Kidney Recipient Selection of Hepatitis C Virus Viremic Donors: Meeting Consensus Report From the 2019 Controversies in Transplantation	17
Balancing Efficiency and Fairness in Liver Transplant Access: Tradeoff Curves for the Assessment of Organ Distribution Policies	17
Antibody Response to a Fourth Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: An Update	17
Breakthrough Infections Following mRNA SARS-CoV-2 Vaccination in Kidney Transplant Recipients	16
Identification of Patient Characteristics Associated With SARS-CoV-2 Infection and Outcome in Kidney Transplant Patients Using Serological Screening	16
Alterations in NKG2A and NKG2C Subsets of Natural Killer Cells Following Epstein–Barr Virus Reactivation in CTLA4Ig-based Haploidentical Transplantation Is Associated With Increased Chronic Graft-Vers	16
Improved Antibody Response After a Fifth Dose of a SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case Series	16
Conversion From Calcineurin Inhibitors to Belatacept in HLA-sensitized Kidney Transplant Recipients With Low-level Donor-specific Antibodies	16
Twenty-year Follow-up of Histocompatibility Leukocyte Antigen-matched Kidney and Bone Marrow Cotransplantation for Multiple Myeloma With End-stage Renal Disease: Lessons Learned	16
The Comparable Efficacy of Lung Donation After Circulatory Death and Brain Death: A Systematic Review and Meta-analysis	16
New Evidence Supporting Increased Use of Split Liver Transplantation	16
A Comprehensive Review of Outcome Predictors in Low MELD Patients	16
Rising Trend in Waitlisting for Alcoholic Hepatitis With More Favorable Outcomes Than Other High Model for End-stage Liver Disease in the Current Era	16
Immune Checkpoint Inhibitors in Transplantation—A Case Series and Comprehensive Review of Current Knowledge	16
Enhanced Humoral Immune Response After COVID-19 Vaccination in Elderly Kidney Transplant Recipients on Everolimus Versus Mycophenolate Mofetil–containing Immunosuppressive Regimens	16
Living Kidney Donor Evaluation	16
Outcomes of Liver Transplantation for Hepatocellular Carcinoma Beyond the University of California San Francisco Criteria: A Single-center Experience	16
Biliary Complications Following Pediatric Living Donor Liver Transplantation: Risk Factors, Treatments, and Prognosis	16
Impact of Acuity Circles on Outcomes for Pediatric Liver Transplant Candidates	16
Preoperative Assessment of Muscle Mass Using Computerized Tomography Scans to Predict Outcomes Following Orthotopic Liver Transplantation	16
Sotrovimab in Solid Organ Transplant Patients With Early, Mild/Moderate SARS-CoV-2 Infection: A Single-center Experience	16
Seeing the Forest for the Trees: Random Forest Models for Predicting Survival in Kidney Transplant Recipients	15
Low Immunization Rate in Kidney Transplant Recipients Also After Dose 2 of the BNT162b2 Vaccine: Continue to Keep Your Guard up!	15
Predicting Early Allograft Function After Normothermic Machine Perfusion	15
Ex Vivo Liver Splitting and Hypothermic Oxygenated Machine Perfusion: Technical Refinements of a Promising Preservation Strategy in Split Liver Transplantation	15
Body Weight Parameters are Related to Morbidity and Mortality After Liver Transplantation: A Systematic Review and Meta-analysis	15
Heterogeneity of Human Pancreatic Islet Isolation Around Europe: Results of a Survey Study	15
Liver Transplantation for Hepatic Epithelioid Hemangioendothelioma Is Facilitated by Exception Points With Acceptable Long-term Outcomes	15
Lung Density Analysis Using Quantitative Chest CT for Early Prediction of Chronic Lung Allograft Dysfunction	15
Risk Factors and Impact of Perioperative Prophylaxis on the Risk of Extended-spectrum β-Lactamase–producing Enterobacteriaceae–related Infection Among Carriers Following Liver Transplantation	15
Decline in Club Cell Secretory Proteins, Exosomes Induction and Immune Responses to Lung Self-antigens, Kα1 Tubulin and Collagen V, Leading to Chronic Rejection After Human Lung Transplantation	15
Prolonged Cold Ischemia Time in Mouse Heart Transplantation Using Supercooling Preservation	15
Peripheral Donor-specific Antibodies Are Associated With Histology and Cellular Subtypes in Protocol Liver Biopsies of Pediatric Recipients	15
Humanization of Immunodeficient Animals for the Modeling of Transplantation, Graft Versus Host Disease, and Regenerative Medicine	15
Update on COVID-19 Therapeutics for Solid Organ Transplant Recipients, Including the Omicron Surge	15
Delayed Implantation of Pumped Kidneys Decreases Renal Allograft Futility in Combined Liver–Kidney Transplantation	15
Immunosuppression Regimen Use and Outcomes in Older and Younger Adult Kidney Transplant Recipients: A National Registry Analysis	15
Effects of Intraoperative Fluid Balance During Liver Transplantation on Postoperative Acute Kidney Injury: An Observational Cohort Study	15
Safety and Feasibility Report of Robotic-assisted Left Lateral Sectionectomy for Pediatric Living Donor Liver Transplantation: A Comparative Analysis of Learning Curves and Mastery Achieved With the L	15
Ten Years of Kidney Paired Donation at Mayo Clinic: The Benefits of Incorporating ABO/HLA Compatible Pairs	15
Long-term Outcomes and Survival in Moderate-severe Portopulmonary Hypertension After Liver Transplant	15
Does Sex, Race, and the Size of a Kidney Transplant Candidate’s Social Network Affect the Number of Living Donor Requests? A Multicenter Social Network Analysis of Patients on the Kidney Transplant Wa	15
Factors Associated With COVID-19 Vaccine Response in Transplant Recipients: A Systematic Review and Meta-analysis	15
Long-term Outcome of Renal Transplantation in Patients with Congenital Lower Urinary Tract Malformations: A Multicenter Study	15
Six-month Antibody Kinetics and Durability in SARS-CoV-2 mRNA Vaccinated Solid Organ Transplant Recipients	15
Antibody-suppressor CD8+ T Cells Require CXCR5	15
Long-term Assessment of NSAID Prescriptions and Potential Nephrotoxicity Risk in Adult Kidney Transplant Recipients	15
SARS-CoV-2-Specific Cell-Mediated Immunity in Kidney Transplant Recipients Recovered from COVID-19.	15
Transplant Suitability of Rejected Human Donor Lungs With Prolonged Cold Ischemia Time in Low-Flow Acellular and High-Flow Cellular Ex Vivo Lung Perfusion Systems	15
A Virtual Crossmatch-based Strategy Facilitates Sharing of Deceased Donor Kidneys for Highly Sensitized Recipients	14
Outcomes of Patients Suspended From the National Kidney Transplant Waiting List in the United Kingdom Between 2000 and 2010	14
SARS-CoV-2 Messenger RNA Vaccine Immunogenicity in Solid Organ Transplant Recipients With Prior COVID-19	14
Patient Survival After Kidney Transplantation: Important Role of Graft-sustaining Factors as Determined by Predictive Modeling Using Random Survival Forest Analysis	14
A Comprehensive Evaluation of Risk Factors for Pneumocystis jirovecii Pneumonia in Adult Solid Organ Transplant Recipients: A Systematic Review and Meta-analysis	14
Living Donor Hepatectomy After Proven SARS-CoV-2 Infection: First Report of 9 Cases From 3 Centers	14
Geographic Disparity in Deceased Donor Liver Transplant Rates Following Share 35	14
Fluid Management During Kidney Transplantation: A Consensus Statement of the Committee on Transplant Anesthesia of the American Society of Anesthesiologists	14
Hypothermic Ex Situ Perfusion of Human Limbs With Acellular Solution for 24 Hours	14
Macrophages in Transplantation: A Matter of Plasticity, Polarization, and Diversity	14
Impact of Red Blood Cells on Function and Metabolism of Porcine Deceased Donor Kidneys During Normothermic Machine Perfusion	14
Outcomes of SARS-CoV-2 Infection in Unvaccinated Compared With Vaccinated Solid Organ Transplant Recipients: A Propensity Matched Cohort Study	14
Effect of Mycophenolate Mofetil Dosing on Antibody Response to SARS-CoV-2 Vaccination in Heart and Lung Transplant Recipients	14
Disappointing Immunization Rate After 2 Doses of the BNT162b2 Vaccine in a Belgian Cohort of Kidney Transplant Recipients	14
Trends in Lung Transplantation Practices Across the United States During the COVID-19 Pandemic	14
Change in Estimated GFR and Risk of Allograft Failure in Patients Diagnosed With Late Active Antibody-mediated Rejection Following Kidney Transplantation	14
Safe Use of Right Lobe Live Donor Livers With up to 20% Macrovesicular Steatosis Without Compromising Donor Safety and Recipient Outcome	14
The Role of SLAs in Xenotransplantation	14
Infectious Complications in Tocilizumab-treated Kidney Transplant Recipients	14
Complement Blockade in Recipients Prevents Delayed Graft Function and Delays Antibody-mediated Rejection in a Nonhuman Primate Model of Kidney Transplantation	13
Hypothermic Machine Perfusion as a National Standard Preservation Method for Deceased Donor Kidneys	13
Deceased Donor–initiated Chains: First Report of a Successful Deliberate Case and Its Ethical Implications	13
Preliminary Clinical Experience of Molnupiravir to Prevent Progression of COVID-19 in Kidney Transplant Recipients	13
Heart Transplantation in Kearns-Sayre Syndrome	13
Unraveling the Crucial Roles of FoxP3+ Regulatory T Cells in Vascularized Composite Allograft Tolerance Induction and Maintenance	13
Histologic Antibody-mediated Kidney Allograft Rejection in the Absence of Donor-specific HLA Antibodies	13
Intraoperative Hemodynamic Parameters and Acute Kidney Injury After Living Donor Liver Transplantation	13
The First Asian Kidney Transplantation Prediction Models for Long-term Patient and Allograft Survival	13
The Utility of ECMO, Not Just After but Also During Liver Transplantation	13
Heart Donation From Donors After Controlled Circulatory Death	13
World Survey on Minimally Invasive Donor Hepatectomy: A Global Snapshot of Current Practices in 2370 Cases	13
Daratumumab for Antibody-mediated Rejection in Heart Transplant—A Novel Therapy: Successful Treatment of Antibody-mediated Rejection	13

Efficacy and Safety of Direct Oral Anticoagulants in Kidney Transplantation: A Single-center Pilot Experience	13
Early Development and Durability of SARS-CoV-2 Antibodies Among Solid Organ Transplant Recipients: A Pilot Study	13
Donor PNPLA3 and TM6SF2 Variant Alleles Confer Additive Risks for Graft Steatosis After Liver Transplantation	13
Defining a Willingness-to-transplant Threshold in an Era of Organ Scarcity: Simultaneous Liver–kidney Transplant as a Case Example	13
A Practical Guide to the Clinical Implementation of Biomarkers for Subclinical Rejection Following Kidney Transplantation	13
Registry of the International Society of Uterus Transplantation: First Report	13
Cellular and Molecular Crosstalk of Graft Endothelial Cells During AMR: Effector Functions and Mechanisms	13
Cardiac Mortality in Kidney Transplant Patients: A Population-based Cohort Study 1988–2013 in Australia and New Zealand	13
A Comprehensive Overview of the Clinical Relevance and Treatment Options for Antibody-mediated Rejection Associated With Non-HLA Antibodies	13
Outcomes of Conversion From Calcineurin Inhibitor to Belatacept-based Immunosuppression in HLA-sensitized Kidney Transplant Recipients	13
Too Much, Too Little, or Just Right? The Importance of Allograft Portal Flow in Deceased Donor Liver Transplantation	12
How Should Pancreas Transplant Rejection Be Treated?	12
Clinicopathologic Characteristics of JC Virus Nephropathy in Kidney Transplant Recipients	12
Validation of Cognitive Impairment in Combination With Physical Frailty as a Predictor of Mortality in Patients With Advanced Heart Failure Referred for Heart Transplantation	12
Bone Mineral Density and Aortic Calcification: Evidence for a Bone-vascular Axis After Kidney Transplantation	12
Higher Proinflammatory Cytokines Are Associated With Increased Antibody Titer After a Third Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients	12
Durvalumab as a Successful Downstaging Therapy for Liver Transplantation in Hepatocellular Carcinoma: The Importance of a Washout Period	12
New-onset Diabetes Mellitus After Adult Heart Transplantation and the Risk of Renal Dysfunction or Mortality	12
Complement 5 Inhibition Ameliorates Hepatic Ischemia/reperfusion Injury in Mice, Dominantly via the C5a-mediated Cascade	12
Changes of T-cell Immunity Over a Lifetime	12
Early Versus Late Hepatocellular Carcinoma Recurrence After Transplantation: Predictive Factors, Patterns, and Long-term Outcome	12
Ex Vivo Analysis of Kidney Graft Viability Using 31P Magnetic Resonance Imaging Spectroscopy	12
Global Estimates of Capacity for Kidney Transplantation in World Countries and Regions	12
Cyclosporin A Administration During Ex Vivo Lung Perfusion Preserves Lung Grafts in Rat Transplant Model	12
Association Between Treatment of Secondary Hyperparathyroidism and Posttransplant Outcomes	12
Further Evidence That the Soluble Urokinase Plasminogen Activator Receptor Does Not Directly Injure Mice or Human Podocytes	12
Ischemia-reperfusion Injury in Allogeneic Liver Transplantation: A Role of CD4 T Cells in Early Allograft Injury	12
Graft-versus-host Disease Prophylaxis With Abatacept Reduces Severe Acute Graft-versus-host Disease in Allogeneic Hematopoietic Stem Cell Transplant for Beta-thalassemia Major With Busulfan, Fludarabi	12
Long-term Kinetics of Intragraft Gene Signatures in Renal Allograft Tolerance Induced by Transient Mixed Chimerism	12
Prediction of Perioperative Cardiovascular Events in Liver Transplantation	12
Safety, Effectiveness, and Tolerability of Patiromer in Kidney Transplant Recipients	12
Age-dependent Sex Differences in Graft Loss After Kidney Transplantation	12
mTOR Inhibitor Therapy Diminishes Circulating CD8+ CD28− Effector Memory T Cells and Improves Allograft Inflammation in Belatacept-refractory Renal Allograft Rejection	12
Area Under Trough Concentrations of Tacrolimus as a Predictor of Progressive Renal Impairment After Liver Transplantation	12
Comparing Donor Heart Assessment Strategies During Ex Situ Heart Perfusion to Better Estimate Posttransplant Cardiac Function	12
An Exceptional Series: 5000 Living Donor Liver Transplantations at Asan Medical Center, Seoul, Korea	12
Ex Vivo Expanded Donor Alloreactive Regulatory T Cells Lose Immunoregulatory, Proliferation, and Antiapoptotic Markers After Infusion Into ATG-lymphodepleted, Nonhuman Primate Heart Allograft Recipien	12
Incidence, Predictors, and Impact on Survival of Long-term Cardiovascular Events After Liver Transplantation	12
Ex Situ Liver Machine Perfusion as an Emerging Graft Protective Strategy in Clinical Liver Transplantation: the Dawn of a New Era	12
Early Outcomes With the Liver-kidney Safety Net	12
T-cell and Antibody Response After 2 Doses of the BNT162b2 Vaccine in a Belgian Cohort of Kidney Transplant Recipients	12
Donor-host Lymphatic Anastomosis After Murine Lung Transplantation	12
Informed Consent for Potential Recipients of Pig Kidney Xenotransplantation in the United States	12
Inactivated Whole-virus Vaccine Triggers Low Response Against SARS-CoV-2 Infection Among Renal Transplant Patients: Prospective Phase 4 Study Results	12
Preemptive Antibody Therapy for Vaccine Breakthrough SARS-CoV-2 Infection in Immunocompromised Patients	11
The Effects of an IL-21 Receptor Antagonist on the Alloimmune Response in a Humanized Mouse Skin Transplant Model	11
Small Split Pediatric Kidneys to Expand the Donor Pool: An Analysis of Scientific Registry of Transplant Recipients (SRTR) Data	11
The Hispanic Paradox in Patients With Liver Cirrhosis: Current Evidence From a Large Regional Retrospective Cohort Study	11
De Novo Focal and Segmental Glomerulosclerosis After COVID-19 in a Patient With a Transplanted Kidney From a Donor With a High-risk APOL1 Variant	11
Successful Liver Transplantation From a Deceased Donor With Vaccine-Induced Thrombotic Thrombocytopenia Causing Cerebral Venous Sinus and Hepatic Veins Thrombosis After ChAdOx1 nCov-19 Vaccination	11
Survival Benefit of Liver Transplantation for Hepatocellular Carcinoma	11
Greater Susceptibility for Metabolic Syndrome in Pediatric Solid Organ and Stem Cell Transplant Recipients	11
Combining Donor-derived Cell-free DNA Fraction and Quantity to Detect Kidney Transplant Rejection Using Molecular Diagnoses and Histology as Confirmation	11
Ex Situ Machine Perfusion of Human Donor Livers via the Surgically Reopened Umbilical Vein: A Proof of Concept	11
Intestinal Dysbiosis Correlates With Sirolimus-induced Metabolic Disorders in Mice	11
Delayed Graft Function in Simultaneous Liver Kidney Transplantation	11
Immediate Postoperative Extubation Decreases Pulmonary Complications in Liver Transplant Patients	11
Mitochondrial Dysfunction and Oxidative Stress in Liver Transplantation and Underlying Diseases: New Insights and Therapeutics	11
The Impact of Portal Vein Thrombosis on Liver Transplant Outcomes: Does Grade or Flow Rate Matter?	11
Monoclonal Antibody Therapy for SARS-CoV-2 Infection in Kidney Transplant Recipients: A Case Series From Belgium	11
Angiotensin II Type-1 Receptor Antibodies Are Associated With Active Allograft Dysfunction Following Pediatric Liver Transplantation	11
Dual MicroRNA Blockade Increases Expression of Antioxidant Protective Proteins: Implications for Ischemia-Reperfusion Injury	11
Trends in COVID-19 Outcomes in Kidney Transplant Recipients During the Period of Omicron Variant Predominance	11
The ILTS Consensus Conference on Transplant Oncology: Setting the Stage	11
The Relationship Between Hypoadiponectinemia and Cardiovascular Events in Liver Transplant Recipients	11
Coronary Artery Disease and Coronary Artery Bypass Grafting at the Time of Lung Transplantation Do Not Impact Overall Survival	11
Bebtelovimab for Treatment of COVID-19 in Ambulatory Solid Organ Transplant Recipients	11
Outcomes After Declining a Steatotic Donor Liver for Liver Transplant Candidates in the United States	11
Clinical Impact, Reactogenicity, and Immunogenicity After the First CoronaVac Dose in Kidney Transplant Recipients	11
Clinical Significance of Alloantibodies in Hand Transplantation: A Multicenter Study	11
Association of Clinical Rejection Versus Rejection on Protocol Biopsy With Cardiac Allograft Vasculopathy in Pediatric Heart Transplant Recipients	11
Activation of HMGB1–TLR4 Pathway and Inflammasome Contribute to Enhanced Inflammatory Response in Extended Criteria and Kidneys With KDPI ≥85%	11
Myocardial Vascular Function Assessed by Dynamic Oxygenation-sensitive Cardiac Magnetic Resonance Imaging Long-term Following Cardiac Transplantation	11
FOXP3 mRNA Profile Prognostic of Acute T Cell–mediated Rejection and Human Kidney Allograft Survival	11
In Vivo Analysis of Human Immune Responses in Immunodeficient Rats	11
BNT162B2 mRNA COVID-19 Vaccine in Heart and Lung Transplanted Young Adults: Is an Alternative SARS-CoV-2 Immune Response Surveillance Needed?	11
Hemodynamic Instability During Liver Transplantation in Patients With End-stage Liver Disease: A Consensus Document from ILTS, LICAGE, and SATA	11
Comparison of Medium-term Outcomes of Living Kidney Donors With Longitudinal Healthy Control in the United Kingdom	11
Minimizing Risks of Liver Transplantation With Steatotic Donor Livers by Preferred Recipient Matching	11
ECMO Long Haulers: A Distinct Phenotype of COVID-19–Associated ARDS With Implications for Lung Transplant Candidacy	10
Natural Killer Cells: Critical Effectors During Antibody-mediated Rejection of Solid Organ Allografts	10
Cold Pulsatile Machine Perfusion Versus Static Cold Storage for Kidneys Donated After Circulatory Death: A Multicenter Randomized Controlled Trial	10
The Challenges With the Cardiac Evaluation of Liver and Kidney Transplant Candidates	10
Wide Variation in the Percentage of Donation After Circulatory Death Donors Across Donor Service Areas: A Potential Target for Improvement	10
Considerations for Use of Domino Cross-auxiliary Liver Transplantation in Metabolic Liver Diseases: A Review of Case Studies	10
Strategies in Organ Preservation—A New Golden Age	10
CXCL9 Predicts Severity at the Onset of Chronic Graft-versus-host Disease	10
Transient-mixed Chimerism With Nonmyeloablative Conditioning Does Not Induce Liver Allograft Tolerance in Nonhuman Primates	10
High Intrapatient Variability in Tacrolimus Exposure Is Not Associated With Immune-mediated Graft Injury After Liver Transplantation	10
Early Kidney Allograft Failure After Simultaneous Liver-kidney Transplantation: Evidence for Utilization of the Safety Net?	10
Emerging Microbiology Diagnostics for Transplant Infections: On the Cusp of a Paradigm Shift	10
Human Lungs Airway Epithelium Upregulate MicroRNA-17 and MicroRNA-548b in Response to Cold Ischemia and Ex Vivo Reperfusion	10
The Implementation of a Multidisciplinary Approach for Potential Organ Donors in the Emergency Department	10
A Comparison of Pulsatile Hypothermic and Normothermic Ex Vivo Machine Perfusion in a Porcine Kidney Model	10
Real-world Outcomes With Rituximab-based Therapy for Posttransplant Lymphoproliferative Disease Arising After Solid Organ Transplant	10
Donor-recipient Sex Differences Do Not Affect Survival Outcomes After Kidney Transplantation: A Population Cohort Study	10
The Higher COVID-19 Fatality Rate Among Kidney Transplant Recipients Calls for Further Action	10
A Pre-TACE Radiomics Model to Predict HCC Progression and Recurrence in Liver Transplantation: A Pilot Study on a Novel Biomarker	10
COVID-19 Infection With the Omicron SARS-CoV-2 Variant in a Cohort of Kidney and Kidney Pancreas Transplant Recipients: Clinical Features, Risk Factors, and Outcomes	10
Survival Benefit of En Bloc Transplantation of Small Pediatric Kidneys in Children	10
The Fourth Dose of CoronaVac Vaccine Results in a Small Increase of Seroconversion and Antibody Values Among Kidney Transplant Recipients	10
Prevention and Management of Donor-transmitted Cancer After Liver Transplantation: Guidelines From the ILTS-SETH Consensus Conference	10
Sotrovimab for Treatment of COVID-19 in Solid Organ Transplant Recipients	10
BET Protein Inhibition Prolongs Cardiac Transplant Survival via Enhanced Myocardial Autophagy	10
Physical Impairment and Access to Kidney Transplantation	10
Unexpected Race and Ethnicity Differences in the US National Veterans Affairs Kidney Transplant Program	10
Clamping of the Aortic Arch Vessels During Normothermic Regional Perfusion After Circulatory Death Prevents the Return of Brain Activity in a Porcine Model	10
Biliary Stricture: The Achilles Heel of Pediatric Living Donor Liver Transplantation	10
Induction Therapy in Elderly Kidney Transplant Recipients With Low Immunological Risk	10
Is 0.6% Reasonable as the Minimum Requirement of the Graft-to-recipient Weight Ratio Regardless of Lobe Selection in Adult Living-donor Liver Transplantation?	10
BK Polyomavirus-specific T Cells as a Diagnostic and Prognostic Marker for BK Polyomavirus Infections After Pediatric Kidney Transplantation	10
Early Allograft Dysfunction and Complications in DCD Liver Transplantation: Expert Consensus Statements From the International Liver Transplantation Society	10
Anti-BAFF Treatment Interferes With Humoral Responses in a Model of Renal Transplantation in Rats	10
Machine Perfusion of the Liver: Applications Beyond Transplantation	10
Weight Gain After Simultaneous Kidney and Pancreas Transplantation	10
The Association Between Cytomegalovirus Infection and Cardiac Allograft Vasculopathy in the Era of Antiviral Valganciclovir Prophylaxis	9
Immunity to Vaccine-preventable Viral Infections in Australians Being Evaluated for Liver Transplantation	9
Consensus Statement on Hemostatic Management, Anticoagulation, and Antiplatelet Therapy in Liver Transplantation	9
Ex Vivo Lung Perfusion: Current Achievements and Future Directions	9
Delayed Kidney Transplantation After 83 Hours of Cold Ischemia Time in Combined Liver-kidney Transplant	9
Meeting Report: Second World Congress of the International Society of Uterus Transplantation, Cleveland	9
Overcoming the Limits of Reconditioning: Seventeen Hours of EVLP With Successful Transplantation From Uncontrolled Circulatory Death Donor	9
Metformin Preconditioning Improves Hepatobiliary Function and Reduces Injury in a Rat Model of Normothermic Machine Perfusion and Orthotopic Transplantation	9
Management of Diabetes in Candidates for Liver Transplantation and in Transplant Recipients	9
Emerging Role of Myeloid-derived Suppressor Cells in the Biology of Transplantation Tolerance	9
Excess Mortality Among Solid Organ Transplant Recipients in the United States During the COVID-19 Pandemic	9
Plasmacytoid Dendritic Cell–driven Induction of Treg Is Strain Specific and Correlates With Spontaneous Acceptance of Kidney Allografts	9
Ex Vivo Lung Perfusion Improves the Inflammatory Signaling Profile of the Porcine Donor Lung Following Transplantation	9
microRNA-145 Inhibition Upregulates SIRT1 and Attenuates Autophagy in a Mouse Model of Lung Ischemia/Reperfusion Injury via NF-κB-dependent Beclin 1	9
Posttransplant Lymphoproliferative Disorder in Pediatric Patients: Characteristics of Disease in EBV-seropositive Recipients	9
Differential Impact of Delayed Graft Function in Deceased Donor Renal Transplant Recipients With and Without Donor-specific HLA-antibodies	9
Kidney Transplantation in HIV-positive Patients: Current Practice and Management Strategies	9
On the Way to Self-sufficiency: Improving Deceased Organ Donation in India	9
Transplant Outcomes in Older Patients With Nonalcoholic Steatohepatitis Compared to Alcohol-related Liver Disease and Hepatitis C	9
Normothermic Ex Situ Heart Perfusion With the Organ Care System for Cardiac Transplantation: A Meta-analysis	9
Early Data on Utilization and Discard of Organs From COVID-19–infected Donors: A US National Registry Analysis	9
Treating Type 1 Diabetes by Pancreas Transplant Alone: A Cohort Study on Actual Long-term (10 Years) Efficacy and Safety	9
Limited Availability of Deceased Uterus Donors: A UK Perspective	9
Solid Organ Transplantation From Donors With COVID-19 Infection	9
Impact of Extra-anatomical Hepatic Artery Reconstruction During Living Donor Liver Transplantation on Biliary Complications and Graft and Patient Survival	9
Financial Feasibility Analysis of a Culturally and Linguistically Competent Hispanic Kidney Transplant Program	9
New Insights Into the Molecular Mechanisms and Immune Control of Cytomegalovirus Reactivation	9
Thrombomodulin-mediated Inhibition of Neutrophil Extracellular Trap Formation Alleviates Hepatic Ischemia-reperfusion Injury by Blocking TLR4 in Rats Subjected to Liver Transplantation	9
Characteristics, Trends, and Outcomes of Liver Transplantation for Primary Sclerosing Cholangitis in Female Versus Male Patients: An Analysis From the European Liver Transplant Registry	9
T-cell Exhaustion in Organ Transplantation	9
Efficacy of Educational Interventions in Improving Measures of Living-donor Kidney Transplantation Activity: A Systematic Review and Meta-analysis	9
Long-term Outcome of Allogeneic Hematopoietic Stem Cell Transplantation From Unrelated Donor Using Tacrolimus/Sirolimus-based GvHD Prophylaxis: Impact of HLA Mismatch	9
Trends in COVID-19 Mortality Among Solid Organ Transplant Recipients: Implications for Prevention	9
Clinical Impact of Antecedent Bariatric Surgery on Liver Transplant Outcomes: A Retrospective Matched Case-control Study	9
Emergency Intraoperative Implantation of ECMO for Refractory Cardiogenic Shock Arising During Liver Transplantation as a Bridge to Myocardial Surgical Revascularization	9
Improved Survival in Liver Transplant Patients Receiving Prolonged-release Tacrolimus-based Immunosuppression in the European Liver Transplant Registry (ELTR): An Extension Study	9
A Primer on Machine Learning	9
Impact of Simultaneous Pancreas-kidney Transplantation on Cardiovascular Risk in Patients With Diabetes	9
A Short Period of Normothermic Machine Perfusion May Not Be Able to Predict Primary Nonfunction in Uncontrolled Circulatory Death Kidneys	9
Predicting Kidney Discard Using Machine Learning	9
Memory T Cells in Transplantation: Old Challenges Define New Directions	9
Obinutuzumab in Kidney Transplantation: Effect on B-cell Counts and Crossmatch Tests	9
DCD Renal Transplantation From Donors With Acute Kidney Injury	9
Polyoma BK Virus in Kidney Transplant Recipients: Screening, Monitoring, and Management	9
Impact of Donor Age on the Outcome of Living-donor Liver Transplantation: Special Consideration to the Feasibility of Using Elderly Donors	9
Prediction of Liver Transplant Rejection With a Biologically Relevant Gene Expression Signature	9
Position Statement of Transplant Activity in the Middle East in Era of COVID-19 Pandemic	9
Long-term Outcomes After Facial Allotransplantation: Systematic Review of the Literature	9
Kidney Allograft Fibrosis: Diagnostic and Therapeutic Strategies	9
Can HLA-B51 Protect Against BKPyV-DNAemia?	9
A Systematic Review for Variables to Be Collected in a Transplant Database for Improving Risk Prediction	9
Perceptions, Barriers, and Experiences With Successful Aging Before and After Kidney Transplantation: A Focus Group Study	9
The Association Between Vena Cava Implantation Technique and Acute Kidney Injury After Liver Transplantation	9
Renal Function Improvement Following ANG-3777 Treatment in Patients at High Risk for Delayed Graft Function After Kidney Transplantation	9
Using Geographic Catchment Areas to Measure Population-based Access to Kidney Transplant in the United States	9
Immunologic Clearance of a BK Virus-associated Metastatic Renal Allograft Carcinoma	9
Meeting Report: First State of the Art Meeting on Gender Disparity in Kidney Transplantation in the Asia-Pacific	9
PCSK9 Inhibitor Use in Heart Transplant Recipients: A Case Series and Review of the Literature	9
Frailty Measures in Patients Listed for Lung Transplantation	9
Characteristics and Outcomes of Heart Transplant Recipients With Coronavirus-19 Disease in a High-volume Transplant Center	9
Cycle Thresholds Among Solid Organ Transplant Recipients Testing Positive for SARS-CoV-2	9
Early Posttransplant Mobilization of Monocytic Myeloid-derived Suppressor Cell Correlates With Increase in Soluble Immunosuppressive Factors and Predicts Cancer in Kidney Recipients	8
Diabetogenic Effects of Immunosuppression: An Integrative Analysis	8
Estimated Glomerular Filtration Rate at Transplant Listing and Other Predictors of Post-Heart Transplant Mortality and the Development of ESRD	8
Injury Pathways That Lead to AKI in a Mouse Kidney Transplant Model	8
Late Onset Invasive Pulmonary Aspergillosis in Lung Transplant Recipients in the Setting of a Targeted Prophylaxis/Preemptive Antifungal Therapy Strategy	8
Patient Travel Distance and Post Lung Transplant Survival in the United States: A Cohort Study	8
A Novel Technique for Bile Duct Division During Laparoscopic Living Donor Hepatectomy to Overcome Biliary Complications in Liver Transplantation Recipients: “Cut and Clip” Rather Than “Clip and Cut”	8
Prevalence and Patterns of Opioid Use Before and After Liver Transplantation	8
COVID-19 in Solid Organ Transplant Recipients: Observations From Connecticut	8
Clinicopathologic Assessment of Monoclonal Immunoglobulin-associated Renal Disease in the Kidney Allograft: A Retrospective Study and Review of the Literature	8
The Role of miR-200b-3p in Modulating TGF-β1–induced Injury in Human Bronchial Epithelial Cells	8
Implications of Fc Neonatal Receptor (FcRn) Manipulations for Transplant Immunotherapeutics	8
Nonopioid Modalities for Acute Postoperative Pain in Abdominal Transplant Recipients	8
The New 2021 CKD-EPI Equation Without Race in a European Cohort of Renal Transplanted Patients	8
Successful Single-kidney Transplantation in Adult Recipients Using Pediatric Donors Aged 8 to 36 Months: Comparable Outcomes With Those Using Pediatric Donors Aged >3 Years	8
Randomized Sirolimus-based Early Calcineurin Inhibitor Reduction in Liver Transplantation: Impact on Renal Function	8
Posttransplant Outcomes for cPRA-100% Recipients Under the New Kidney Allocation System	8
Preemptive Kidney Transplantation Is Associated With Transplantation Outcomes in Children: Results From the French Kidney Replacement Therapy Registry	8
Imlifidase-generated Single-cleaved IgG: Implications for Transplantation	8
Race, Education, and Gender Disparities in Transplantation of Kidneys From Hepatitis C Viremic Donors	8
Tolerance Biomarkers in Liver Transplantation: Independent External Validation of the Predictive Strength of SENP6 and FEM1C Gene Expression	8
Therapeutic Hypothermia in Organ Donors: Follow-up and Safety Analysis	8
Executive Functioning in Pediatric Solid Organ Transplant Recipients: A Meta-analytic Review	8
A 2-fold Approach to Polyoma Virus (BK) Nephropathy in Kidney Transplants: Distinguishing Direct Virus Effects From Cognate T Cell–mediated Inflammation	8